AGP Picks
View all

Infasurf market report points to steady growth through 2035

Nov. 5, 2026
Infasurf market report points to steady growth through 2035
By AI, Created 00:30 UTC, Nov 05, 2026, AGP -

The Business Research Company says the Infasurf market will keep expanding through 2035, driven by more preterm births, higher neonatal healthcare spending and wider NICU access. North America is projected to lead in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Infasurf is used to treat respiratory distress syndrome in premature infants, so demand tracks neonatal care needs and preterm birth rates. - The market outlook points to continued expansion in neonatal healthcare infrastructure, surfactant therapy adoption and hospital spending. - The report frames Infasurf as part of a broader shift toward earlier, more standardized respiratory treatment for newborns.

What happened: - The Business Research Company released its Infasurf Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on November 5, 2026. - The report covers market size, growth drivers, regional outlook and forecast trends across major geographies. - The company also promoted a free sample report and a full market report online: More information and the full report.

The details: - Infasurf is a natural lung surfactant derived from bovine lungs. - The product contains phospholipids including dipalmitoyl phosphatidylcholine. - The surfactant reduces surface tension in the lungs and supports gas exchange. - The treatment is used primarily for premature infants with respiratory distress syndrome. - Historical market growth has been supported by high neonatal respiratory distress syndrome rates, proven surfactant replacement therapy, NICU expansion, better premature-infant survival and wider hospital use of surfactants. - Future growth is expected to be supported by rising global preterm birth rates, higher neonatal healthcare spending, better access to NICU care, surfactant formulation innovation and expanded neonatal care infrastructure. - The report highlights expected trends including greater use of natural lung surfactants, higher preterm birth rates, improved neonatal intensive care protocols, earlier respiratory distress intervention and broader standardization of surfactant therapy for newborns. - The market analysis spans Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - North America is projected to hold the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report says it adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, key technology and future-trend analysis, and updated graphics and tables.

Between the lines: - Rising preterm births are the clearest demand driver, because they directly increase the number of infants who may need surfactant therapy. - Higher healthcare spending can support adoption by making neonatal treatments more accessible and by reducing the cost burden of longer hospital stays and complex respiratory care. - Wider awareness of infant respiratory disorders points to earlier diagnosis and treatment, which can lift utilization of products like Infasurf. - The regional split suggests a mature market in North America and a faster-growth opportunity in emerging neonatal care markets in Asia-Pacific.

What's next: - The report expects demand to continue rising as NICU capacity and neonatal care investment grow worldwide. - Market watchers should expect more focus on surfactant standardization, early intervention protocols and product innovation through 2035. - The Business Research Company lists company contacts for follow-up and report access, including email and regional phone numbers.

The bottom line: - Infasurf’s outlook is tied to one core trend: more premature births will keep driving neonatal surfactant demand, especially as healthcare systems expand care for newborns.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Latin American Newswire

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Latin American Newswire

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.